Antibiotic-lock therapy: a clinical viewpoint

References

• Sotir MJ, Lewis C, Bisher EW, Ray SM, Soucie JM, Blumberg HM. Epidemiology of device-associated infections related to a long-term implantable vascular access device. Infect. Control. Hosp. Epidemiol. 20, 187–191 (1999).
   PubMed Web of Science ®Google Scholar
• Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo. Clin. Proc. 81, 1159–1171 (2006).
   PubMed Web of Science ®Google Scholar
• Mermel LA, Allon M, Bouza E et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49, 1–45 (2009).
   PubMed Web of Science ®Google Scholar
• Bestul MB, Vandenbussche HL. Antibiotic lock technique: review of the literature. Pharmacotherapy 25, 211–227 (2005).
   PubMed Web of Science ®Google Scholar
• Segarra-Newnham M, Martin-Cooper EM. Antibiotic lock technique: a review of the literature. Ann. Pharmacother. 39, 311–318 (2005).
   PubMed Web of Science ®Google Scholar
• Del Pozo JL. Role of antibiotic lock therapy for the treatment of catheter-related bloodstream infections. Int. J. Artif. Organs. 32, 678–688 (2009).
   PubMedGoogle Scholar
• Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J. Parenter. Enteral Nutr. 12, 185–189 (1988).
   PubMed Web of Science ®Google Scholar
• Messing B. Catheter-sepsis during home parenteral nutrition: use of the antibiotic-lock technique. Nutrition 14, 466–468 (1998).
   PubMedGoogle Scholar
• Capdevila JA, Segarra A, Planes AM et al. Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol. Dial. Transplant. 8, 231–234 (1993).
   PubMed Web of Science ®Google Scholar
• Benoit JL, Carandang G, Sitrin M, Arnow PM. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin. Infect. Dis. 21, 1286–1288 (1995).
   PubMed Web of Science ®Google Scholar
• Carratalà J. The antibiotic-lock technique for therapy of ‘highly needed’ infected catheters. Clin. Microbiol. Infect. 8, 282–289 (2002).
   PubMed Web of Science ®Google Scholar
• Viale P, Pagani L, Petrosillo N et al. Antibiotic lock-technique for the treatment of catheter-related bloodstream infections. J. Chemother. 15, 152–156 (2003).
   PubMed Web of Science ®Google Scholar
• Rao JS, O’Meara A, Harvey T, Breatnach F. A new approach to the management of Broviac catheter infection. J. Hosp. Infect. 22, 109–116 (1992).
   PubMed Web of Science ®Google Scholar
• Johnson DC, Johnson FL, Goldman S. Preliminary results treating persistent central venous catheter infections with the antibiotic lock technique in pediatric patients. Pediatr. Infect. Dis. J. 13, 930–931 (1994).
   PubMed Web of Science ®Google Scholar
• Krzywda EA, Andris DA, Edmiston CE Jr, Quebbeman EJ. Treatment of Hickman catheter sepsis using antibiotic lock technique. Infect. Control. Hosp. Epidemiol. 16, 596–598 (1995).
   PubMed Web of Science ®Google Scholar
• Krishnasami Z, Carlton D, Bimbo L et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int. 61, 1136–1142 (2002).
   PubMed Web of Science ®Google Scholar
• Guedon C, Nouvellon M, Lalaude O, Lerebours E. Efficacy of antibiotic-lock technique with teicoplanin in staphylococcus epidermidis catheter-related sepsis during long-term parenteral nutrition. JPEN J. Parenter. Enteral Nutr. 26, 109–113 (2002).
   PubMed Web of Science ®Google Scholar
• Donlan RM. Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner. Clin. Infect. Dis. 52, 1038–1045 (2011).
   PubMedGoogle Scholar
• Pascual A. Pathogenesis of catheter-related infections: lessons for new designs. Clin. Microbiol. Infect. 8, 256–264 (2002).
   PubMed Web of Science ®Google Scholar
• Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann. Intern. Med. 127, 275–280 (1997).
   PubMed Web of Science ®Google Scholar
• O’Horo JC, Silva GL, Safdar N. Anti-infective locks for treatment of central line-associated bloodstream infection: a systematic review and meta-analysis. Am. J. Nephrol. 34, 415–422 (2011).
   PubMedGoogle Scholar
• Cremieux AC, Maziere B, Vallois JM et al. Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography. J. Infect Dis. 159, 938–944 (1989).
   PubMed Web of Science ®Google Scholar
• Stewart PS, Davison WM, Steenbergen JN. Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm. Antimicrob. Agents Chemother. 53, 3505–3507 (2009).
   PubMed Web of Science ®Google Scholar
• Raad I, Hanna H, Jiang Y et al. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob. Agents Chemother. 51, 1656–1660 (2007).
   PubMed Web of Science ®Google Scholar
• Fernández-Hidalgo N, Gavaldà J, Almirante B et al. Evaluation of linezolid, vancomycin, gentamicin and ciprofloxacin in a rabbit model of antibiotic-lock technique for Staphylococcus aureus catheter-related infection. J. Antimicrob. Chemother. 65, 525–530 (2010).
   PubMed Web of Science ®Google Scholar
• Van Praagh AD, Li T, Zhang S et al. Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections. Antimicrob. Agents Chemother. 55, 4081–4089 (2011).
   PubMedGoogle Scholar
• Domínguez-Herrera J, Docobo-Pérez F, López-Rojas R et al. Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis. Antimicrob. Agents Chemother. 56, 613–617 (2012).
   PubMed Web of Science ®Google Scholar
• Anthony TU, Rubin LG. Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports). Antimicrob. Agents Chemother. 43, 2074–2076 (1999).
   PubMed Web of Science ®Google Scholar
• Fernandez-Hidalgo N, Almirante B, Calleja R et al. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. J. Antimicrob. Chemother. 57, 1172–1180 (2006).
   PubMed Web of Science ®Google Scholar
• Maya ID, Carlton D, Estrada E, Allon M. Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report. Am. J. Kidney Dis. 50, 289–295 (2007).
   PubMed Web of Science ®Google Scholar
• Walraven CJ, Lee SA. Antifungal lock therapy. Antimicrob. Agents Chemother. 57, 1–8 (2013).
   PubMed Web of Science ®Google Scholar
• Poole CV, Carlton D, Bimbo L, Allon M. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol. Dial. Transplant. 19, 1237–1244 (2004).
   PubMed Web of Science ®Google Scholar
• Fortún J, Grill F, Martín-Dávila P et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J. Antimicrob. Chemother. 58, 816–821 (2006).
   PubMed Web of Science ®Google Scholar
• Del Pozo JL, Rodil R, Aguinaga A et al. Daptomycin lock therapy for grampositive long-term catheter-related bloodstream infections. Int. J. Clin. Pract. 66, 305–308 (2012).
   PubMedGoogle Scholar
• Del Pozo JL, Alonso M, Serrera A, Hernaez S, Aguinaga A, Leiva J. Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections. Diagn. Microbiol. Infect. Dis. 63, 208–212 (2009).
   PubMed Web of Science ®Google Scholar
• Funalleras G, Fernández-Hidalgo N, Borrego A et al. Effectiveness of antibiotic-lock therapy for long-term catheter-related bacteremia due to Gram-negative bacilli: a prospective observational study. Clin. Infect. Dis. 53, e129–e132 (2011).
   PubMed Web of Science ®Google Scholar
• Joshi AJ, Hart PD. Antibiotic catheter locks in the treatment of tunneled hemodialysis catheter-related blood stream infection. Semin. Dial. 26, 223–226 (2013).
   PubMedGoogle Scholar
• Cornely OA, Bassetti M, Calandra T, et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin. Microbiol. Infect. 18(Suppl. 7), 19–37 (2012).
   PubMed Web of Science ®Google Scholar
• Mascio CT, Alder JD, Silverman JA. Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells. Antimicrob. Agents. Chemother. 51, 4255–4260 (2007).
   PubMed Web of Science ®Google Scholar
• Broom J, Woods M, Allworth A, et al. Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial. Scand. J. Infect. Dis. 40, 399–406 (2008).
   PubMed Web of Science ®Google Scholar
• McGrath EJ, Salloum R, Chen X, et al. Short-dwell ethanol lock therapy in children is associated with increased clearance of central line-associated bloodstream infections. Clin. Pediatr. (Phila). 50, 943–951 (2011).
   PubMedGoogle Scholar
• Onland W, Shin CE, Fustar S, Rushing T, Wong WY. Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients. Arch. Pediatr. Adolesc. Med. 160, 1049–1053 (2006).
   PubMedGoogle Scholar
• Sloobe L, Doorduijn JK, Luqtenburg PJ, et al. Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters. a randomized, placebo-controlled trial. PLoS ONE 5, e10840 (2010).
   PubMedGoogle Scholar
• Bradshaw JH, Puntis JW. Taurolidine and catheter-related bloodstream infection: a systematic review of the literature. J. Pediatr. Gastroenterol. Nutr. 47, 179–186 (2008).
   PubMedGoogle Scholar
• Dümichen MJ, Seeger K, Lode HN, et al. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies. J. Hosp. Infect. 80, 304–309 (2012).
   PubMed Web of Science ®Google Scholar
• Turakhia MH, Cooksey KE, Characklis WG. Influence of a calcium-specific chelant of biofilm removal. Appl. Environ. Microbiol. 46, 1236–1238 (1983).
   PubMed Web of Science ®Google Scholar
• Raad II, Fang X, Keutgen XM, Jiang Y, Sherertz R, Hachem R. The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr. Opin. Infect. Dis. 21, 385–392 (2008).
   PubMed Web of Science ®Google Scholar
• Bookstaver PB, Williamson JC, Tucker BK, Raad II, Sherertz RJ. Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections. Ann. Pharmacother. 43, 210–219 (2009).
   PubMed Web of Science ®Google Scholar
• Raad I, Rosenblatt J, Reitzel R, Jiang Y, Dvorak T, Hachem R. Chelator-based catheter-solutions in eradicating organisms in biofilm. Antimicrob. Agents. Chemother. 57, 586–588 (2013).
   PubMed Web of Science ®Google Scholar
• Chauhan A, Lebeaux D, Ghigo JM, Beloin C. Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy. Antimicrob. Agents. Chemother. 56, 6310–6318 (2012).
   PubMed Web of Science ®Google Scholar
• Allison KR, Brynildsen MP, Collins JJ. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature. 473(7346), 216–220 (2011).
   PubMed Web of Science ®Google Scholar
• Cirioni O, Giacometti A, Ghiselli R, et al. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. J. Infect. Dis. 193, 180–186 (2006).
   PubMed Web of Science ®Google Scholar
• Lewis K. Riddle of biofilm resistance. Antimicrob. Agents. Chemother. 45, 999–1007 (2001).
   PubMed Web of Science ®Google Scholar
• Boles BR, Horswill AR. Agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathog. 4, e1000052 (2008).
   PubMed Web of Science ®Google Scholar
• Fey PD. Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections? Curr. Opin. Microbiol. 13, 610–615 (2010).
   PubMed Web of Science ®Google Scholar
• Cobrado L, Azevedo MM, Silva-Dias A, Ramos JP, Pina-Vaz C, Rodrigues AG. Cerium, chitosan and hamamelitannin as novel biofilm inhibitors? J. Antimicrob. Chemother. 67, 1159–1162 (2012).
   PubMedGoogle Scholar
• Ebert T, Smith S, Pancari G et al. Development of a rat central venous catheter model for evaluation of vaccines to prevent Staphylococcus epidermidis and Staphylococcus aureus early biofilms. Hum. Vaccin. 7, 630–638 (2011).
   PubMed Web of Science ®Google Scholar
• Mansouri MD, Hull RA, Stager CE, Cadle RM, Darouiche RO. In vitro activity and durability of a combination of an antibiofilm and an antibiotic against vascular catheter colonization. Antimicrob. Agents. Chemother. 57, 621–625 (2013).
   PubMedGoogle Scholar
• Castagnola E, Ginocchio F. Rescue therapy of difficult-to-treat indwelling central venous catheter-related bacteremias in cancer patients: a review for practical purposes. Expert. Rev. Anti. Infect. Ther. 11, 179–186 (2013).
   PubMed Web of Science ®Google Scholar
• Messing B, Man F, Colimon R, Thuillier F, Beliah M. Antibiotic-lock technique is an effective treatment of bacterial catheter-related sepsis during parenteral nutrition. Clin. Nutr. 9, 220–225 (1990).
   PubMedGoogle Scholar
• Williams N, Carlson GL, Scott NA, Irving MH. Incidence and management of catheter-related sepsis in patients receiving home parenteral nutrition. Br. J. Surg. 81, 392–394 (1994).
   PubMed Web of Science ®Google Scholar
• McCarthy A, Byrne M, Breathnach F, O’Meara A. “In-situ” teicoplanin for central venous catheter infection. Ir. J. Med. Sci. 164:125–127 (1995).
   PubMedGoogle Scholar
• Capdevila JA, Segarra A, Planes AM et al. Long-term follow-up of patients with catheter-related bacteremia treated without catheter removal. Clin. Microbiol. Infect. 4, 472–476 (1998).
   Google Scholar
• Domingo P, Fontanet A, Sánchez F, Allende L, Vazquez G. Morbidity associated with long-term use of totally implantable ports in patients with AIDS. Clin. Infect. Dis. 29, 346–351 (1999).
   PubMed Web of Science ®Google Scholar
• Piketty C, Hoï AB, Gilquin J et al. Failure of antibiotic therapy in Staphylococcus epidermidis infection of implantable venous access devices in patients with AIDS, as documented by molecular typing. Clin. Microbiol. Infect. 5, 190–194 (1999).
   PubMedGoogle Scholar
• Boorgu R, Dubrow AJ, Levin NW et al. Adjunctive antibiotic/anticoagulant lock therapy in the treatment of bacteremia associated with the use of a subcutaneously implanted hemodialysis access device. ASAIO J. 46, 767–770 (2000).
   PubMed Web of Science ®Google Scholar
• Fourcade J, Mallaval FO, Raffenot D, Mercier D, Maret J, Morel B. [Value of an antibiotic lock for the prevention of bacteremia recurrence from central catheters in chronic hemodialysis]. Nephrologie 22, 457–458 (2001).
   PubMedGoogle Scholar
• Longuet P, Douard MC, Arlet G, Molina JM, Benoit C, Leport C. Venous access port--related bacteremia in patients with acquired immunodeficiency syndrome or cancer: the reservoir as a diagnostic and therapeutic tool. Clin. Infect. Dis. 32, 1776–1783 (2001).
   PubMedGoogle Scholar
• Bailey E, Berry N, Cheesbrough JS. Antimicrobial lock therapy for catheter-related bacteraemia among patients on maintenance haemodialysis. J. Antimicrob. Chemother. 50, 615–617 (2002).
   PubMed Web of Science ®Google Scholar
• Santarpia L, Pasanisi F, Alfonsi L et al. Prevention and treatment of implanted central venous catheter (CVC) - related sepsis: a report after six years of home parenteral nutrition (HPN). Clin. Nutr. 21, 207–211 (2002).
   PubMedGoogle Scholar
• Reimund JM, Arondel Y, Finck G, Zimmermann F, Duclos B, Baumann R. Catheter-related infection in patients on home parenteral nutrition: results of a prospective survey. Clin. Nutr. 21, 33–38 (2002).
   PubMedGoogle Scholar
• Cuntz D, Michaud L, Guimber D, Husson MO, Gottrand F, Turck D. Local antibiotic lock for the treatment of infections related to central catheters in parenteral nutrition in children. JPEN. J. Parenter. Enteral Nutr. 26, 104–108 (2002).
   PubMedGoogle Scholar
• Vardhan A, Davies J, Daryanani I, Crowe A, McClelland P. Treatment of haemodialysis catheter-related infections. Nephrol. Dial. Transplant. 17, 1149–1150 (2002).
   PubMed Web of Science ®Google Scholar
• Koldehoff M, Zakrzewski JL. Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients. Int. J. Antimicrob. Agents 24, 491–495 (2004).
   PubMed Web of Science ®Google Scholar
• De Sio L, Jenkner A, Milano GM et al. Antibiotic lock with vancomycin and urokinase can successfully treat colonized central venous catheters in pediatric cancer patients. Pediatr. Infect. Dis. J. 23, 963–965 (2004).
   PubMed Web of Science ®Google Scholar
• Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J. Antimicrob. Chemother. 55, 90–94 (2005).
   PubMed Web of Science ®Google Scholar
• Sánchez-Muñoz A, Aguado JM, López-Martín A et al. Usefulness of antibiotic-lock technique in management of oncology patients with uncomplicated bacteremia related to tunneled catheters. Eur. J. Clin. Microbiol. Infect. Dis. 24, 291–293 (2005).
   PubMed Web of Science ®Google Scholar
• Bernardi M, Cavaliere M, Cesaro S. [The antibiotic-lock therapy in oncoematology pediatric unit]. Assist. Inferm. Ric. 24, 127–131 (2005).
   PubMedGoogle Scholar
• Lee HR, Lee YK, Song YL et al. Treatment of catheter-related bacteremia with an antibiotic lock protocol in hemodialysis patients. Korean J. Nephrol. 24, 903–911 (2005).
   Google Scholar
• Souza Dias MB, Habert AB, Borrasca V et al. Salvage of long-term central venous catheters during an outbreak of Pseudomonas putida and Stenotrophomonas maltophilia infections associated with contaminated heparin catheter-lock solution. Infect. Control Hosp. Epidemiol. 29, 125–140 (2008).
   PubMed Web of Science ®Google Scholar
• Del Pozo JL, García Cenoz M, Hernáez S et al. Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis. Int. J. Antimicrob. Agents 34, 482–485 (2009).
   PubMed Web of Science ®Google Scholar
• Beigi AA, Khansoltani S, Masoudpour H, Atapour AA, Eshaghian A, Khademi EF. Influence of intralumenal and antibiotic-lock of vancomycin on the rate of catheter removal in the patients with permanent hemodialysis catheters. Saudi. J. Kidney. Dis. Transpl. 21, 54–58 (2010).
   PubMedGoogle Scholar
• Blackwood RA, Klebin KC, Micel LN, et al. Ethanol locks therapy for resolution of fungal catheter infections. Pediatr. Infect. Dis. J. 30, 1105–1107 (2011).
   PubMed Web of Science ®Google Scholar